Digital Technologies for Tuberculosis Treatment Adherence

Summary

Tuberculosis remains a leading cause of infectious mortality worldwide, with treatment adherence posing a critical challenge to control efforts. Conventional directly observed therapy (DOT) can impose significant burdens on patients and health services, especially in resource-limited settings. Digital adherence technologies (DATs) offer patient-centred alternatives by harnessing mobile phones, sensors and cloud-based platforms to monitor and support medication intake remotely. Common approaches include short message service (SMS) reminders, electronic medication monitors that log box openings, and video-observed therapy (VOT) in which patients record and transmit ingestion events. These innovations aim to reduce clinic visits, optimise healthcare resources and enable real-time risk stratification. Early implementation studies reveal improvements in adherence metrics and patient satisfaction, yet persistent challenges—such as network coverage, device charging, digital literacy and data privacy—must be addressed. As global health programmes seek scalable solutions, robust evidence on clinical effectiveness, cost-effectiveness and equitable access remains a priority.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

A meta-analysis of user and health-worker feedback found that digital adherence platforms were broadly acceptable, scoring high on capability, opportunity and motivation among people with tuberculosis and their supervisors. Technical obstacles—such as intermittent network coverage, device malfunction and intermittent electricity—were identified as key barriers, prompting recommendations to integrate support systems and minimise out-of-pocket costs for patients.

A scoping review of digital health interventions classified approaches into SMS reminders, electronic medicine monitors and web-based DOT. While most studies demonstrated improvements in treatment success rates and reduced missed doses, few addressed interactive, two-way communication or feedback loops. The review emphasised the need for bidirectional messaging to foster engagement and self-management.

A qualitative study of a low-cost mobile phone-based platform in Uganda highlighted both facilitators and obstacles to implementation. Patients and providers valued the simplicity and relationship-building aspects of the system, but barriers such as limited phone access, concerns over stigma, literacy challenges and gender-related disparities affected uptake. Tailored strategies were recommended to ensure inclusive adoption and sustained engagement.

Digital Technologies for Tuberculosis Treatment Adherence publication trend

The graph below shows the total number of articles in digital technologies for tuberculosis treatment adherence across all publications each year (not limited to Nature Index journals).

Technical terms

Digital adherence technology (DAT): digital tools and platforms designed to monitor and support patient medication-taking behaviour.

Directly observed therapy (DOT): traditional approach in which a healthcare worker or designated observer supervises each dose of medication intake.

Video-observed therapy (VOT): remote method of treatment supervision involving patients recording and transmitting videos of medication intake.

Short message service (SMS): text messaging system used to send reminders or prompts to patients via mobile phones.

mHealth: use of mobile and wireless technologies to deliver health interventions and services.

References

  1. Acceptability and feasibility of digital adherence technologies for drug-susceptible tuberculosis treatment supervision: A meta-analysis of implementation feedback. PLOS Digital Health (2023).
  2. Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review. JMIR mHealth and uHealth (2023).
  3. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study. Journal of Medical Internet Research (2023).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.